Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gail Maderis Insider Profile
11 Followers
Gail Maderis, Director at Acer Therapeutics, holds 200.00K shares in Durect (Ticker: DRRX), holds 6.52K shares in Acer Therapeutics (Ticker: ACER), holds 0.00 shares in NovaBay Pharma (Ticker: NBY). Most recently, Gail Maderis Bought ― shares of Durect on Aug 12, 2022 for an estimated value of 17.89K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-56.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Gail Maderis
Gail Maderis's Trading History
Acer Therapeutics
Oct 04, 2016
―
Uninformative Buy
―
$4.30K
Durect
Aug 12, 2022
Director
Informative Buy
17.89K
$192.00K
NovaBay Pharma
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Gail Maderis's performance on stock
You May Also Like
Gail Maderis insider profile FAQ
What is the percentage of profitable transactions made by Gail Maderis?
The percentage of profitable transactions made by Gail Maderis is 0%.
What is the average return per transaction made by Gail Maderis?
The average return per transaction made by Gail Maderis is -56.30%.
What stocks does Gail Maderis hold?
Gail Maderis holds: ACER, DRRX, NBY stocks.
What was Gail Maderis’s latest transaction?
Gail Maderis latest transaction was an Informative Buy of $17.89K.
What was Gail Maderis's most profitable transaction?
Gail Maderis’s most profitable transaction was an Informative Buy of DRRX stock on August 11, 2022. The return on the trade was -54.00%.
What is Gail Maderis's role in Acer Therapeutics?
Gail Maderis's role in Acer Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.